Literature DB >> 35316088

Can Automated Alerts in the Electronic Health Record Encourage Referrals for Genetic Counseling and Testing Among Patients at High Risk for Hereditary Cancer Syndromes?

Kristin K Zorn1, Melinda E Simonson1, Jennifer L Faulkner1, Cyndee L Carr1, Joshua Acuna1, Tiffany L Hall1, John F Jenkins1, Karen L Drummond1, Geoffrey M Curran1.   

Abstract

PURPOSE: Up to 10% of cancers may be associated with an inherited mutation that increases cancer risk. National guidelines emphasize referral for genetic counseling and testing for patients whose personal and/or family history increases their risk of having a hereditary cancer syndrome.
METHODS: To increase appropriate referrals for cancer genetic counseling and testing, we piloted an automated alert known as a Best Practice Advisory (BPA) in the electronic health record, Epic, to notify oncology providers when a patient had a personal and/or family history that merited referral to cancer genetics. Epic could not gather the complex clinical data needed for the referral decision automatically, necessitating staff completion of a questionnaire. After educating providers, the BPA was implemented with resources to support its use.
RESULTS: Initial interaction with the alert was high but rapidly dwindled, resulting in questionnaire completion in 7.2% of more than 32,000 encounters and 14.9% of patients over 9 months. However, cancer genetics referrals increased 95.9% during the pilot (P < .0001), with 18.5% placed through the BPA and the rest from a non-BPA mechanism. Semistructured interviews with key stakeholders revealed not only general acceptance of the BPA concept but also barriers to completion, such as pressure to room patients quickly in the face of competing BPAs and lack of buy-in from some providers.
CONCLUSION: These results suggest that provider engagement and BPA fatigue are significant obstacles to acceptance of a new automated alert. Despite interest in a tool for cancer genetics, the demand on clinical time for this complex BPA was poorly tolerated.

Entities:  

Mesh:

Year:  2022        PMID: 35316088      PMCID: PMC9287297          DOI: 10.1200/OP.21.00641

Source DB:  PubMed          Journal:  JCO Oncol Pract        ISSN: 2688-1527


  11 in total

1.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

Review 2.  Why do physicians have difficulty accepting clinical decision support systems?

Authors:  David T Marc; Saif S Khairat
Journal:  Stud Health Technol Inform       Date:  2013

Review 3.  Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.

Authors:  Brian Drohan; Constance A Roche; James C Cusack; Kevin S Hughes
Journal:  Ann Surg Oncol       Date:  2012-03-17       Impact factor: 5.344

Review 4.  Hereditary Colorectal Cancer Syndromes.

Authors:  Katerina Wells; Paul E Wise
Journal:  Surg Clin North Am       Date:  2017-06       Impact factor: 2.741

Review 5.  Hereditary ovarian cancer: beyond the usual suspects.

Authors:  Kathryn P Pennington; Elizabeth M Swisher
Journal:  Gynecol Oncol       Date:  2012-02       Impact factor: 5.482

6.  The search for unaffected individuals with Lynch syndrome: do the ends justify the means?

Authors:  Heather Hampel; Albert de la Chapelle
Journal:  Cancer Prev Res (Phila)       Date:  2011-01

7.  Exploring barriers and facilitators to the use of computerized clinical reminders.

Authors:  Jason J Saleem; Emily S Patterson; Laura Militello; Marta L Render; Greg Orshansky; Steven M Asch
Journal:  J Am Med Inform Assoc       Date:  2005-03-31       Impact factor: 4.497

8.  Clinical reminders designed and implemented using cognitive and organizational science principles decrease reminder fatigue.

Authors:  Lee A Green; Donald Nease; Michael S Klinkman
Journal:  J Am Board Fam Med       Date:  2015 May-Jun       Impact factor: 2.657

9.  Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population.

Authors:  Ranjit Manchanda; Oleg Blyuss; Faiza Gaba; Vladimir Sergeevich Gordeev; Chris Jacobs; Matthew Burnell; Carmen Gan; Rohan Taylor; Clare Turnbull; Rosa Legood; Alexey Zaikin; Antonis C Antoniou; Usha Menon; Ian Jacobs
Journal:  J Med Genet       Date:  2018-04-05       Impact factor: 6.318

10.  A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.

Authors:  Heather Hampel; Robin L Bennett; Adam Buchanan; Rachel Pearlman; Georgia L Wiesner
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.